Acquisition Announced
Tarsus Pharmaceuticals acquisition of iRenix Medical
US$75m consideration
Announced 8 Jul 2026
Advisers
- Target
- iRenix Medical
- Acquirer
- Tarsus Pharmaceuticals
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Ophthalmology
- Tags
- Ophthalmology, Drug Development, Pharma
In the league tables
Similar deals
- Shionogi & Co. acquisition of Shionogi-Apnimed Sleep Science Apr 2026 · US$100m · Pharma
- Harrow acquisition of TYRVAYA (varenicline solution) nasal spray 0.03 mg Aug 2026 · US$30m · Pharma
- Bayer acquisition of Perfuse Therapeutics May 2026 · US$300m · Biotech
- Amneal Pharmaceuticals acquisition of Kashiv BioSciences Apr 2026 · US$375m · Biotech
- Tarsus Pharmaceuticals acquisition of Alkeus Pharmaceuticals Aug 2026 · US$450m · Biotech